Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
23 hedge funds and large institutions have $36.3M invested in Chembio diagnostics, Inc. in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
40% more capital invested
Capital invested by funds: $25.9M → $36.3M (+$10.4M)
10% more funds holding
Funds holding: 21 → 23 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIP
ARS Investment Partners
New York
|
+$593K |
| 2 |
RA
Royce & Associates
New York
|
+$545K |
| 3 |
BCA
Benchmark Capital Advisors
New York
|
+$227K |
| 4 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$196K |
| 5 |
VF
Virtu Financial
New York
|
+$75.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$67.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$57.4K |
| 3 |
FMA
FNY Managed Accounts
New York
|
-$17K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$14.2K |
| 5 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$9K |
CEMI Hedge Fund Activity: Q4 2017 in Review
23 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q4 2017, worth a combined $36.3M — up 40% from $25.9M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CEMI positions and 3 closed out — a net gain of 2 holders — while 8 added to existing stakes and 3 trimmed.
The largest buyer was ARS Investment Partners, adding an estimated $593K. The largest seller was Perkins Capital Management, cutting an estimated $67.7K.
- 23 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q4 2017, up from 21 in Q3 2017.
- Funds reported $36.3M of Chembio diagnostics, Inc. stock for Q4 2017, up 40% quarter-over-quarter.
- 5 funds opened new Chembio diagnostics, Inc. positions in Q4 2017 and 3 closed out, a net change of +2 holders.
- The largest Chembio diagnostics, Inc. buyer in Q4 2017 was ARS Investment Partners, an estimated $593K added.
- The largest Chembio diagnostics, Inc. seller in Q4 2017 was Perkins Capital Management, an estimated $67.7K sold.
Based on aggregated 13F filings for Q4 2017.